NCT04418986

Brief Summary

Today, cataract surgery is regarded as refractive surgery, mainly aiming emmetropia, and this makes eliminating corneal astigmatism is critical. Corneal astigmatism of more than 1 diopter has been reported in up to 45% of the cataract surgery candidates. It is possible to reduce pre-existing corneal astigmatism by creating a clear corneal incision at the steep meridian of the cornea, however; creating a small incision can correct the only astigmatism up to 1 Diopter, and sometimes this method may not be easy to perform due to the location of steep meridian like the difficulty while creating a superonasal or inferonasal incision at the left eye. This approach is usually sufficient for correcting astigmatism less than 1 D in most eyes. An opposite side clear corneal incision (OCCI) could enhance the flattening effect on the cornea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jul 2019

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 5, 2020

Completed
Last Updated

June 5, 2020

Status Verified

June 1, 2020

Enrollment Period

3 months

First QC Date

June 3, 2020

Last Update Submit

June 3, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean astigmatic correction

    Astigmatic correction change after the correction surgery

    After 1 month of surgery

  • Mean surgically induced astigmatism

    Mean surgically induced astigmatism, measured by a vector-corrected method

    After 1 month of surgery

Secondary Outcomes (1)

  • Change in visual acuity

    After 1 month of surgery

Study Arms (2)

Control (CCI Group)

SHAM COMPARATOR

The Participants will undergo phacoemulsification with on-axis incision

Procedure: opposite clear corneal incisions (OCCI)

Study (OCCI Group)

ACTIVE COMPARATOR

The Participants will undergo phacoemulsification with opposite clear corneal incisions

Procedure: opposite clear corneal incisions (OCCI)

Interventions

Coaxial small incision cataract surgery was performed for all cases using a 2.8 mm keratome placed at steep meridian and 1-mm paracentesis was made 90 degrees apart with a 20-gauge microvitrectomy blade. Surgery was performed with a 30-degree, 0.9-caliper phacoemulsification tip (microtip) with a divide and conquer technique. In the OCCI group, a single penetrating incision was created with 2.8 mm keratome in the clear cornea, 1.5 mm anterior to limbal blood vessels, centered over the steep meridian and opposite the phacoemulsification incision.

Control (CCI Group)Study (OCCI Group)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clear cornea
  • No history of previous ocular surgery
  • Central corneal thickness (CCT) \<640

You may not qualify if:

  • Irregular corneal astigmatism or lenticular astigmatism
  • Corneal opacities or pathology like Fuch's endothelial dystrophy
  • Previous ocular surgeries like glaucoma surgery or PKP or pterygium excision
  • Posterior segment diseases and pathology
  • Complicated phacoemulsification

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghazi al-Hariri Surgical Specialties Hospital

Baghdad, Bab-Almuadham, 12221, Iraq

Location

MeSH Terms

Conditions

Astigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A randomized, parallel two-arm interventional study, the patients were divided into a 1:1 ratio, the study included eyes with visually significant cataract and preoperative corneal regular astigmatism between 0.75 and 2 Diopters undergoing phacoemulsification surgery. They were divided into two groups: controls underwent phacoemulsification with on-axis incision (CCI Group), and patients underwent phacoemulsification with opposite clear corneal incisions (OCCI Group).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2020

First Posted

June 5, 2020

Study Start

July 1, 2019

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

June 5, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations